Product Information
THEOPHYLLINE ER 450 MG TABLET is a generic product labeled by Leading Pharma, LLC, priced at $0.9799 per EA under NDC 69315022701. Its NADAC has been published 67 times since Mar 19, 2025.
Strength
450 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315022701
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
THEOPHYLLINEApproval Type
Generic (ANDA)
FDA Application
ANDA214950On Market Since
5/15/2023
Pharmacological Classes
Price Statistics
The NADAC for THEOPHYLLINE ER 450 MG TABLET has been published 67 times since Mar 19, 2025, and over the history we have for it it has declined 48.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9799 per EA |
|---|---|
| All-time high | $1.9133 (Apr 16, 2025) |
| All-time low | $0.5902 (Nov 19, 2025) |
| 52-week high | $1.4468 |
| 52-week low | $0.5902 |
| Median price | $1.1149 |
| Average price | $1.1848 |
| Largest weekly change | +45.0% (Dec 17, 2025) |
| Weeks tracked | 67 |
| Tracking since | Mar 19, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the THEOPHYLLINE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of THEOPHYLLINE ER 450 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for THEOPHYLLINE ER 450 MG TABLET, manufactured by Leading Pharma, LLC, is $0.9799 per EA (NDC 69315022701), effective Jun 24, 2026.
How has the price of THEOPHYLLINE ER 450 MG TABLET changed over time?
Over the history we have for it, the NADAC for THEOPHYLLINE ER 450 MG TABLET has declined 48.8%. It has been tracked across 67 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for THEOPHYLLINE ER 450 MG TABLET?
Since Mar 19, 2025, the NADAC for THEOPHYLLINE ER 450 MG TABLET has ranged from a low of $0.5902 (Nov 19, 2025) to a high of $1.9133 (Apr 16, 2025), with a median of $1.1149 per EA.
Are there cheaper alternatives to THEOPHYLLINE ER 450 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of THEOPHYLLINE ER 450 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures THEOPHYLLINE ER 450 MG TABLET?
THEOPHYLLINE ER 450 MG TABLET (NDC 69315022701) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification